Irritable Bowel Syndrome with Diarrhea
📧 Sign up to get email alerts when something new happens for Irritable Bowel Syndrome with Diarrhea.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: A Study of Brenipatide (LY3537031) in Participants With Irritable Bowel Syndrome-Diarrhea (IBS-D) [Phase 2]
A Phase 2 clinical trial evaluating Brenipatide (LY3537031) for irritable bowel syndrome with diarrhea; the study is currently not recruitin…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Efficacy of Rifaximin With NAC in IBS-D [Phase 2]
Phase 2 clinical trial evaluating the efficacy of rifaximin in combination with N-acetylcysteine for diarrhea-predominant irritable bowel sy…
-
CLINICAL_TRIALS research · 2026-01-06Clinical Trial Update: Screening of Lactose Intolerance Among IBS Patients Diarrhea Dominant
A planned study sponsored by Assiut University will screen lactose intolerance in patients with diarrhea-predominant irritable bowel syndrom…
-
CLINICAL_TRIALS research · 2025-12-18Clinical Trial Update: Novel Pilot Study to Treat Symptoms of IBS With Diarrhea Using Combination Therapy of a Low-FODMAP Diet and a Neuromodulator [EARLY_Phase 1]
A novel pilot Phase 1 study is testing a combination of a low-FODMAP diet and a neuromodulator to treat symptoms of irritable bowel syndrome…
-
CLINICAL_TRIALS research · 2025-11-20Clinical Trial Update: Use of A Complex Gut Bacterial Consortium (MITI 001) for the Treatment of Irritable Bowel Syndrome With Diarrhea [EARLY_Phase 1]
Early-phase clinical trial update for MITI 001, a complex gut bacterial consortium, aimed at treating irritable bowel syndrome with diarrhea…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-09-19Clinical Trial Update: Study to Explore the Therapeutic Effect of Eluxadoline in Treating Irritable Bowel Syndrome With Diarrhea in Children [Phase 2]
Phase 2 clinical trial update investigating eluxadoline for irritable bowel syndrome with diarrhea in pediatric patients. Recruitment is cur…
-
CLINICAL_TRIALS research · 2025-08-20Clinical Trial Update: Effect of Ebastine in Patients With Diarrhea Predominant Irritable Bowel Syndrome [Phase 2, Phase 3]
A Phase 2/3 clinical trial evaluating ebastine for diarrhea-predominant irritable bowel syndrome is currently recruiting.
-
CLINICAL_TRIALS research · 2025-05-13Clinical Trial Update: The Role of Fiber in the Prevention and Treatment of Fecal Incontinence [NA]
A completed clinical trial evaluating the role of dietary fiber in preventing and treating fecal incontinence.
-
CLINICAL_TRIALS research · 2025-05-07Clinical Trial Update: Efficacy of Repeated Transcranial Magnetic Stimulation Combined With a Live Probiotic Tablet (Combined Bifidobacterium, Lactobacillus, Enterococcus and Bacillus Cereus Tablets, Live) in Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D) [Phase 1]
This is a Phase 1 clinical trial evaluating the efficacy of repeated transcranial magnetic stimulation combined with a live probiotic tablet…
-
CLINICAL_TRIALS research · 2025-04-03Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Live SK08 Powder in Patients With IBS-D [Phase 3]
A Phase 3 study to evaluate the efficacy and safety of Live SK08 Powder in patients with Irritable bowel syndrome with diarrhea is currently…
-
CLINICAL_TRIALS research · 2025-02-20Clinical Trial Update: Efficacy of Chatbot for Irritable Bowel Syndrome (IBS) Patients [NA]
A clinical trial update shows ongoing enrollment for a study assessing the efficacy of a chatbot intervention in patients with various forms…
-
CLINICAL_TRIALS research · 2024-09-25Clinical Trial Update: B.Subtilis Attenuate Symptoms in Diarrhea-predominant Irritable Bowel Syndrome by Increasing Hypoxanthine Biosynthesis [EARLY_Phase 1]
An early-phase (Phase 1) trial evaluating Bacillus subtilis (B.Subtilis) to relieve symptoms of diarrhea-predominant irritable bowel syndrom…
-
CLINICAL_TRIALS research · 2022-04-19Clinical Trial Update: Changes in Microbiota and Metabolomic Profile Between Rifaximin Responders and Non-responders In Diarrhoea-Predominant Irritable Bowel Syndrome [Phase 4]
Phase 4 trial update exploring differences in gut microbiota and metabolomic profiles between rifaximin responders and non-responders in dia…
-
CLINICAL_TRIALS research · 2020-07-28Clinical Trial Update: Effects of Continuous Treatment With Rifaximin and Probiotics on the Gut Microbiota of Patients With IBS-D [Phase 4]
Phase 4 trial investigating continuous rifaximin with probiotics on gut microbiota in irritable bowel syndrome with diarrhea patients.